The Association Between Inflammatory and Oxidative Stress Biomarkers and Plasma Metabolites in a Longitudinal Study of Healthy Male Welders.
inflammation
metabolism
metabolomics
metals
occupational health
particulates
phospholipids
Journal
Journal of inflammation research
ISSN: 1178-7031
Titre abrégé: J Inflamm Res
Pays: New Zealand
ID NLM: 101512684
Informations de publication
Date de publication:
2021
2021
Historique:
received:
21
04
2021
accepted:
02
06
2021
entrez:
8
7
2021
pubmed:
9
7
2021
medline:
9
7
2021
Statut:
epublish
Résumé
Human metabolism and inflammation are closely related modulators of homeostasis and immunity. Metabolic profiling is a useful tool to understand the association between metabolism and inflammation at a systemic level. To investigate the longitudinal associations between the concentration of plasma metabolites and biomarkers related to inflammation and oxidative stress. We conducted a repeated cross-sectional analysis consisting of 8 short-term panels that included 88 healthy adult male welders in Massachusetts, USA. In each panel, we collected 1-6 repeated measurements of blood and urine. We used a human vascular injury panel assay and custom cytokine/chemokine assay to quantify inflammatory biomarker plasma levels, liquid chromatography-mass spectrometry to quantify the concentrations of 665 plasma metabolites, and a competitive enzyme-linked immunoassay to quantify urinary 8-OHdG and 8-isoprostane levels. We used linear mixed effects models to estimate the longitudinal association between each inflammatory and oxidative stress biomarker and each metabolite. At a 5% FDR threshold, we detected ≥1metabolite association for 8 unique inflammatory and oxidative stress biomarkers: urinary 8-isoprostane, plasma C-reactive protein (CRP), serum amyloid A (SAA), intercellular adhesion molecule 1, circulating vascular cell adhesion molecule-1, interleukin 8 (IL-8), interleukin 10 (IL-10) and vascular endothelial growth factor. Specifically, 3 metabolites in the androgenic steroids pathway were negatively associated with SAA; 3 dihydrosphingomyelins metabolites were positively associated with 1 or more of CRP, SAA, IL-8 and IL-10; 4 metabolites in acyl choline metabolism pathways were negatively associated with IL-8; 7 lysophospholipid metabolites were negatively associated with 1 or more of CRP, SAA and IL-8; 4 sphingomyelins were positively associated with CRP and/or SAA; and 10 metabolites in the xanthine pathway were positively associated with urinary 8-isoprostane. We found that metabolites in phospholipid groups had strong associations with multiple inflammatory biomarkers, especially CRP, SAA and IL-8. The mechanism of these associations warrants further investigation.
Identifiants
pubmed: 34234508
doi: 10.2147/JIR.S316262
pii: 316262
pmc: PMC8254568
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2825-2839Subventions
Organisme : NIEHS NIH HHS
ID : R01 ES009860
Pays : United States
Organisme : ACL HHS
ID : T42OH008416
Pays : United States
Informations de copyright
© 2021 Gao et al.
Déclaration de conflit d'intérêts
There was no conflict of interested reported by any of the authors.
Références
J Biol Chem. 2009 Mar 6;284(10):6038-42
pubmed: 19112107
Cells. 2019 Jul 19;8(7):
pubmed: 31331111
Psychometrika. 1967 Sep;32(3):241-54
pubmed: 5234703
Cold Spring Harb Perspect Biol. 2014 Sep 04;6(10):a016295
pubmed: 25190079
Eur Cytokine Netw. 2006 Mar;17(1):4-12
pubmed: 16613757
J Biomed Inform. 2015 Feb;53:156-61
pubmed: 25445923
Circ Res. 2004 Oct 15;95(8):764-72
pubmed: 15486323
Occup Environ Med. 2021 Apr;78(4):255-261
pubmed: 33106349
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Circ Res. 2005 Apr 29;96(8):838-46
pubmed: 15790954
Circulation. 2003 Jan 28;107(3):499-511
pubmed: 12551878
Cytokine. 2014 Sep;69(1):136-45
pubmed: 24746243
Cell. 2010 Sep 3;142(5):687-98
pubmed: 20813258
Vasc Cell. 2011 Apr 20;3:9
pubmed: 21507243
Chem Rev. 2011 Oct 12;111(10):5973-96
pubmed: 21848345
Circulation. 2004 Jul 27;110(4):380-5
pubmed: 15262834
J Occup Environ Med. 2008 Feb;50(2):182-9
pubmed: 18301175
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
J Gerontol A Biol Sci Med Sci. 2017 Sep 01;72(9):1277-1283
pubmed: 26975982
Toxicol Rep. 2020 Oct 11;7:1350-1355
pubmed: 33102138
FASEB J. 1999 Jun;13(9):1025-30
pubmed: 10336884
Circulation. 2003 Jul 15;108(2):150-4
pubmed: 12847067
Nat Rev Immunol. 2015 Aug;15(8):511-23
pubmed: 26139350
Cell Metab. 2012 May 2;15(5):635-45
pubmed: 22560216
Circ Res. 2009 Jul 17;105(2):114-27
pubmed: 19608989
Am J Physiol Endocrinol Metab. 2010 Nov;299(5):E832-40
pubmed: 20823453
Circulation. 2003 Jan 28;107(3):391-7
pubmed: 12551861
Biochem Biophys Res Commun. 2007 Mar 23;354(4):1084-8
pubmed: 17276402
Nat Immunol. 2011 May;12(5):408-15
pubmed: 21478880
Nat Rev Immunol. 2015 Feb;15(2):104-16
pubmed: 25614320
Circulation. 1999 Jul 6;100(1):96-102
pubmed: 10393687
Biochem J. 1997 Nov 15;328 ( Pt 1):271-5
pubmed: 9359864
Curr Opin Lipidol. 2009 Jun;20(3):182-9
pubmed: 19369869
Front Nutr. 2019 Aug 26;6:129
pubmed: 31508422
J Biochem. 1987 Feb;101(2):331-8
pubmed: 3495531
Int J Cancer. 2011 May 1;128(9):2038-49
pubmed: 20648559
Eur J Clin Nutr. 2012 Apr;66(4):426-35
pubmed: 21952696
Toxicol Lett. 2020 Aug 1;328:19-27
pubmed: 32320775
PLoS One. 2014 Jan 27;9(1):e87348
pubmed: 24475279
J Biol Chem. 2002 Jan 11;277(2):1085-91
pubmed: 11694522
J Biol Chem. 2010 Apr 2;285(14):10638-52
pubmed: 20129920
Circulation. 2003 Jul 15;108(2):126-8
pubmed: 12860890
Circ Res. 2020 May 22;126(11):1549-1564
pubmed: 32437299